Fogarty Siobhan 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Fogarty Siobhan
Chief Technology Officer
Transactions
- Award
Stock Option
2025-02-25+13,500→ 13,500 totalExercise: $8.05From: 2026-02-25Exp: 2035-02-25→ Common Stock (13,500 underlying) - Award
Stock Option
2025-02-25+13,500→ 13,500 totalExercise: $10.06From: 2026-02-25Exp: 2035-02-25→ Common Stock (13,500 underlying)
Footnotes (2)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.